Farmaci oncologici

Queste aziende sviluppano o vendono farmaci contro il cancro, come pillole, anticorpi, terapie cellulari e vaccini.
+15,1%
in 3 mesi · S&P 500 −2,1%

Indicatori chiave

Salute
49 / 100
Fragile
Solido
Prezzo
P/E 40
Economico
Caro
In rialzo su 1 anno
57 su 105
Wallet su 90 giorni
2 / 5 acquisti / vendite
Acquisti
Vendite
Salute e prezzo: rispetto agli altri tag.

Le 113 aziende

LLY
+22,0%
JNJ
+9,4%
ABBV
+17,9%
MRK
Dimensione: peso nel tag. Colore: variazione nel periodo.
Vedi tutte le aziende
L
Eli Lilly
LLY
33,3%
+22,0%
J
Johnson & Johnson
JNJ
16,5%
+9,4%
A
AbbVie
ABBV
12,9%
+17,9%
M
Merck
MRK
9,0%
+9,3%
A
Amgen
AMGN
6,2%
+11,7%
G
Gilead Sciences
GILD
5,2%
+21,7%
P
Pfizer
PFE
4,1%
+9,1%
B
Bristol-Myers Squibb
BMY
3,1%
−0,8%
R
Regeneron Pharmaceuticals
REGN
2,3%
+18,7%
M
Moderna
MRNA
2,2%
+246,5%
R
Revolution Medicines
RVMD
1,1%
−18,7%
I
Incyte
INCY
0,6%
−2,0%
E
Exelixis
EXEL
0,4%
+31,9%
S
Summit Therapeutics
SMMT
0,3%
+10,7%
C
Corcept Therapeutics
CORT
0,2%
−37,7%
I
ImmunityBio
IBRX
0,2%
−24,0%
C
CG Oncology
CGON
0,2%
−3,5%
E
Erasca
ERAS
0,1%
−14,3%
C
Cogent Biosciences
COGT
0,1%
−24,6%
L
Legend Biotech
LEGN
<0,1%
−15,3%
R
Relay Therapeutics
RLAY
<0,1%
−12,5%
T
Tango Therapeutics
TNGX
<0,1%
+0,8%
E
Enliven Therapeutics
ELVN
<0,1%
−18,0%
I
Iovance Biotherapeutics
IOVA
<0,1%
+9,3%
P
Parabilis Medicines
PBLS
<0,1%
−23,6%
C
Celcuity
CELC
<0,1%
−30,4%
I
IDEAYA Biosciences
IDYA
<0,1%
−12,9%
X
Xencor
XNCR
<0,1%
+60,4%
R
Arcus Biosciences
RCUS
<0,1%
−41,0%
B
Biohaven
BHVN
<0,1%
−4,4%
I
Immunome
IMNM
<0,1%
−31,5%
R
Recursion Pharmaceuticals
RXRX
<0,1%
+2,4%
R
Replimune Group
REPL
<0,1%
+49,6%
V
Vir Biotechnology
VIR
<0,1%
+6,1%
Z
Zymeworks
ZYME
<0,1%
+3,7%
S
SELLAS Life Sciences
SLS
<0,1%
−39,5%
P
Precigen
PGEN
<0,1%
−30,7%
N
Nurix Therapeutics
NRIX
<0,1%
−43,0%
N
Nuvation Bio
NUVB
<0,1%
−38,4%
T
Tyra Biosciences
TYRA
<0,1%
−23,6%
D
Damora Therapeutics
DMRA
<0,1%
−30,5%
I
Inhibrx
INBX
<0,1%
−9,5%
V
Verastem
VSTM
<0,1%
+13,9%
C
Corvus Pharmaceuticals
CRVS
<0,1%
−28,6%
A
Aktis Oncology
AKTS
<0,1%
−32,8%
O
Oric Pharmaceuticals
ORIC
<0,1%
−41,3%
S
Syndax Pharmaceuticals
SNDX
<0,1%
−52,2%
R
Rigel Pharmaceuticals
RIGL
<0,1%
+4,7%
O
Obsidian Therapeutics
OBX
<0,1%
−28,4%
A
Aura Biosciences
AURA
<0,1%
−7,4%
S
Sana Biotechnology
SANA
<0,1%
−45,1%
C
Cullinan Therapeutics
CGEM
<0,1%
−50,1%
F
Fulgent Genetics
FLGT
<0,1%
+32,2%
N
Nuvectis Pharma
NVCT
<0,1%
+6,1%
D
Delcath Systems
DCTH
<0,1%
+20,5%
K
Kura Oncology
KURA
<0,1%
−31,1%
C
Candel Therapeutics
CADL
<0,1%
−49,0%
O
Olema Pharmaceuticals
OLMA
<0,1%
−29,8%
J
Janux Therapeutics
JANX
<0,1%
−30,1%
B
Bicara Therapeutics
BCAX
<0,1%
−59,8%
A
ArriVent BioPharma
AVBP
<0,1%
−55,2%
G
Geron
GERN
<0,1%
−36,8%
C
Crescent Biopharma
CBIO
<0,1%
−19,1%
M
Monopar Therapeutics
MNPR
<0,1%
−38,2%
C
CytomX Therapeutics
CTMX
<0,1%
−40,9%
B
BlossomHill Therapeutics
BLSM
<0,1%
−14,4%
A
Arvinas
ARVN
<0,1%
−25,9%
R
Relmada Therapeutics
RLMD
<0,1%
−11,7%
P
Puma Biotechnology
PBYI
<0,1%
−11,9%
C
C4 Therapeutics
CCCC
<0,1%
−35,3%
F
Faeth Therapeutics
FTH
<0,1%
−69,4%
E
Eikon Therapeutics
EIKN
<0,1%
−42,9%
A
Agenus
AGEN
<0,1%
−5,9%
A
Allogene Therapeutics
ALLO
<0,1%
−59,7%
I
Immuneering
IMRX
<0,1%
−28,9%
C
Cypherpunk Technologies
CYPH
<0,1%
+165,1%
Z
Zentalis Pharmaceuticals
ZNTL
<0,1%
−54,1%
S
Sutro Biopharma
STRO
<0,1%
−55,9%
A
ALX Oncology
ALXO
<0,1%
−47,2%
F
Fate Therapeutics
FATE
<0,1%
−51,1%
I
Inovio Pharmaceuticals
INO
<0,1%
+24,3%
P
PDS Biotechnology
PDSB
<0,1%
+295,7%
C
Perspective Therapeutics
CATX
<0,1%
−70,7%
C
Corbus Pharmaceuticals
CRBP
<0,1%
−67,7%
A
Acrivon Therapeutics
ACRV
<0,1%
−29,3%
A
ABVC BioPharma
ABVC
<0,1%
+7,1%
A
Actuate Therapeutics
ACTU
<0,1%
−71,2%
A
Allarity Therapeutics
ALLR
<0,1%
−28,8%
A
AIM ImmunoTech
AIM
<0,1%
−40,9%
B
BioAtla
BCAB
<0,1%
−43,3%
A
Ascentage Pharma Group International
AAPG
−19,7%
A
Adagene
ADAG
−55,4%
A
ADC Therapeutics
ADCT
+21,8%
A
Adlai Nortye
ANL
−20,5%
A
Autolus Therapeutics
AUTL
−48,7%
A
AstraZeneca
AZN
+17,6%
B
BioNTech
BNTX
−6,6%
E
Electra Therapeutics
ETRA
G
Genmab
GMAB
+56,4%
G
GSK
GSK
+0,3%
H
HUTCHMED
HCM
+18,6%
I
Iambic Therapeutics
IAM
I
Immunocore
IMCR
−14,6%
I
Immatics
IMTX
−30,9%
J
Jazz Pharmaceuticals
JAZZ
−2,7%
N
Nanobiotix
NBTX
−27,1%
N
Novartis
NVS
+5,6%
O
BeOne Medicines
ONC
+14,9%
R
Roche Holdings
RHHBY
0,0%
T
Takeda Pharmaceutical
TAK
+23,3%
T
Telix Pharmaceuticals
TLX
−21,3%
U
UroGen Pharma
URGN
−46,7%
Z
Zai Lab
ZLAB
−4,1%